TrialCardiovascular diabetology2025
Dapagliflozin modulates plasma lipidomic profile and urinary metabolite excretion in type 2 diabetes.
Samantha Pezzica et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it